Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan · Delayed Price · Currency is TWD 180.50
-2.00 (-1.10%)
Jan 13, 2026, 11:46 AM CST
Lumosa Therapeutics Market Cap
Lumosa Therapeutics has a market cap or net worth of 30.74 billion as of January 12, 2026. Its market cap has increased by 7.08% in one year.
Market Cap
30.74B
Enterprise Value
29.92B
Revenue
42.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
180.50
Market Cap Chart
Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 30.74B, an increase of 615.83%. That is a compound annual growth rate of 20.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 30.74B | -6.17% |
| Dec 31, 2025 | 32.77B | -22.40% |
| Dec 31, 2024 | 42.22B | 274.74% |
| Dec 29, 2023 | 11.27B | 75.37% |
| Dec 30, 2022 | 6.43B | 5.04% |
| Dec 30, 2021 | 6.12B | 17.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 228.62B |
| PharmaEssentia | 189.36B |
| Lotus Pharmaceutical | 76.92B |
| Bora Pharmaceuticals Co., LTD. | 64.12B |
| Heron Neutron Medical | 59.70B |
| Oneness Biotech | 33.15B |
| Center Laboratories | 30.53B |
| Lin BioScience | 30.28B |